Investor Alerts: PFSweb (NASDAQ:PFSW), TCP Capital (NASDAQ:TCPC), Warren Resources (NASDAQ:WRES), WuXi Pharmatech Cayman Inc. (NYSE:WX)

PFSweb (NASDAQ:PFSW) is higher after the company on Thursday reported better-than-expected financial results for Q4. Shares are up 3.18% at $9.09 in late-morning Thursday trade, near its 52-week high of $9.60. The eCommerce firm reported Q4 non-GAAP earnings of $0.06 per share, compared with the prior-year period’s $0.07 per share. The Capital IQ consensus estimate was for $0.02 per share.

PFSweb (NASDAQ:PFSW)’s GAAP loss for the quarter was $0.03 per share, compared with GAAP earnings of $0.05 per share. Revenue was $66.7 million, down from $77 million in the same quarter last year. The decrease in total revenues was primarily due to the expected decline in product revenue to $21.3 million compared to $28.3 million in the same period in 2012 as a result of restructuring activities by the company’s largest client in this segment.

Analysts were expecting revenues of $50.98 million. PFSweb (NASDAQ:PFSW) said it is currently targeting fiscal 2014 service fee equivalent revenue of $127 million – $133 million, increasing 7% – 12% from 2013. It is also targeting adjusted EBITDA in fiscal 2014 of $12 million – $14 million, representing an increase of 12% – 31% from 2013.

TCP Capital (NASDAQ:TCPC) is higher after the company reported Q4 net investment income declined year-over-year on a per share basis, though said net assets increased. Shares are up 1.55% at $17.65, with a 52-week range of $14.87 – $18.15.

The externally managed, non-diversified closed-end management investment company reported Q4 net investment income was $16.3 million, or $0.51 per share, before related incentive compensation and preferred dividends.

TCP Capital (NASDAQ:TCPC) net investment income same period last year was approximately $14.0 million, or $0.65 per share, before preferred dividends and excise taxes. Net increase in net assets resulting from operations for the current quarter was $14.4 million, or $0.46 per share, compared with $6.9 million, or $0.32 per share, in the comparable quarter a year ago.

Warren Resources (NASDAQ:WRES) was up nearly 2% in early trade as its Q4 earnings and sales topped analysts’ expectations. The oil and gas exploration and production company said its Q4 non-GAAP adjusted income rose to $0.11 per share from $0.07 the year earlier, beating the $0.09 average estimate from analysts polled by Capital IQ.

Warren Resources (NASDAQ:WRES)’s revenue rose to $32.61 million from $31.90 million a year ago, coming in just ahead of the $32 million consensus estimate. Total net income applicable to shareholders slipped however to $3.7 million from $4.0 million due to $3.4 million in unrealized, non-cash losses on commodity derivatives resulting from mark to market accounting and $0.7 million of non-recurring G&A related to severance expenses.

Warren Resources (NASDAQ:WRES) shares were down 2.67% in morning trading.

WuXi Pharmatech Cayman Inc. (NYSE:WX) fell 7.8% after providing disappointing earnings guidance. The contract drug researcher estimates Q1 expects revenue of $143 million to $145 million and earnings per ADS of $0.36 to $0.38, compared with the analyst forecast on Capital IQ of $154 million in revenue and earnings per ADS of $0.40.

For the full year 2014, the company expects revenue of $660 million to $670 million and earnings per ADS of $1.95 to $2.00, compared with the Street view of $667 million in revenue and earnings of $1.89 per ADS. WuXi (NYSE:WX) reported Q4 2013 revenue of $157.2 million, up 25.1% from the prior year and in line with the analyst consensus.

Earnings per ADS was $0.53, ahead of expectations of $0.46 per share. WuXi (NYSE:WX) fell 7.8% to $36.30 per ADS on Thursday. It reached a 52-week high of $40.72 on February 25.